The Globe & Mail

SaNOtize Research and Development Corp. of Vancouver, announced on Wednesday that it has received approval from Health Canada to begin a clinical trial of its method, which hinges on the delivery of nitric oxide gas to the upper-respiratory tract.

Canadian company SaNOtize Research aims to limit COVID-19 spread with nasal spray